Axillary Sentinel Lymph Node Biopsy in Patients With Pure Ductal Carcinoma In Situ of the Breast | Breast Cancer | JAMA Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Rebner  MRaju  U Noninvasive breast cancer.  Radiology. 1994;190623- 631Google Scholar
Lagios  MD Duct carcinoma in situ: pathology and treatment.  Surg Clin North Am. 1990;70853- 871Google Scholar
Schnitt  SJSilen  WSadowsky  NL  et al.  Ductal carcinoma in situ.  N Engl J Med. 1988;318898- 902Google ScholarCrossref
Cox  CENguyen  KGray  RJ  et al.  Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?  Am Surg. 2001;67513- 519Google Scholar
Giuliano  AEDale  PSTurner  RRMorton  DLEvans  SWKrasne  DL Improved axillary staging of breast cancer with sentinel lymphadenectomy.  Ann Surg. 1995;222394- 399Google ScholarCrossref
Nasser  IALee  AKBosari  S  et al.  Occult axillary lymph node metastases in "node-negative" breast carcinoma.  Hum Pathol. 1993;24950- 957Google ScholarCrossref
Hainsworth  PJTjandra  JJStillwell  RG  et al.  Detection and significance of occult metastases in node-negative breast cancer.  Br J Surg. 1993;80459- 463Google ScholarCrossref
McGuckin  MACummings  MCWalsh  MD  et al.  Occult axillary node metastases in breast cancer: their detection and prognostic significance.  Br J Cancer. 1996;7388- 95Google ScholarCrossref
Cote  RJPeterson  HFChaiwun  B  et al. International Breast Cancer Study Group, Role of immunohistochemical detection of lymph-node metastases in management of breast cancer.  Lancet. 1999;354896- 900Google ScholarCrossref
Dowlatshahi  KFan  MBloom  KJSpitz  DJPatel  SSnider Jr  HC Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: a preliminary study.  Cancer. 1999;86990- 996Google ScholarCrossref
Pendas  SDauway  EGiuliano  RKu  NNCox  CEReintgen  DS Sentinel node biopsy in DCIS patients.  Ann Surg Oncol. 2000;715- 20Google ScholarCrossref
Klauber-DeMore  NTan  LKLiberman  L  et al.  Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?  Ann Surg Oncol. 2000;7636- 642Google ScholarCrossref
De Cicco  CCremonesi  MLuini  A  et al.  Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.  J Nucl Med. 1998;392080- 2084Google Scholar
De Cicco  CPizzamiglio  MTrifiro  G  et al.  Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer: technical aspects.  Q J Nucl Med. 2002;46145- 151Google Scholar
Rosen  PPOberman  H Tumors of the Mammary Gland.  Washington, DC Armed Forces Institute of Pathology1993;
Holland  RPeterse  JLMillis  RR  et al.  Ductal carcinoma in situ: a proposal for a new classification.  Semin Diagn Pathol. 1994;11167- 180Google Scholar
Veronesi  UPaganelli  GViale  G  et al.  Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.  J Natl Cancer Inst. 1999;91368- 373Google ScholarCrossref
Page  DAnderson  T Metastasis of breast cancer.  Diagnostic Histopathology of the Breast. Edinburgh, Scotland Churchill Livingstone1988;321- 322Google Scholar
Veronesi  UZurrida  SMazzarol  GViale  G Extensive frozen section examination of axillary sentinel nodes to determine selective axillary dissection.  World J Surg. 2001;25806- 808Google ScholarCrossref
Lagios  MDSilverstein  MJ Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction.  Ann Surg Oncol. 2001;8275- 277Google ScholarCrossref
Carter  BAJensen  RASimpson  JFPage  DL Benign transport of breast epithelium into axillary lymph nodes after biopsy.  Am J Clin Pathol. 2000;113259- 265Google ScholarCrossref
Original Article
March 2003

Axillary Sentinel Lymph Node Biopsy in Patients With Pure Ductal Carcinoma In Situ of the Breast

Author Affiliations

From the Departments of Breast Surgery (Drs Intra, P. Veronesi, Galimberti, Luini, Gentilini, Naninato, Torres, and U. Veronesi), Pathology and Laboratory Medicine (Drs Mazzarol, Pruneri, and Viale), and Nuclear Medicine (Drs Trifir[[ograve]] and Paganelli), European Institute of Oncology, Milan, Italy; Department of Pathology, University of Milan School of Medicine, Milan (Drs Mazzarol, Pruneri, and Viale); and the Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY (Dr Sacchini).

Arch Surg. 2003;138(3):309-313. doi:10.1001/archsurg.138.3.309

Hypothesis  A sentinel lymph node (SLN) biopsy should not be considered a standard procedure in the treatment of all patients with ductal carcinoma in situ (DCIS) of the breast if the lesion is completely excised by radical surgery and there are free margins of resection.

Design  Prospective case series.

Setting  Department of breast surgery of a comprehensive cancer center.

Patients  From January 1, 1998, to December 1, 2001, 223 unselected consecutive patients affected by pure DCIS of the breast underwent an SLN biopsy.

Results  Metastases in the SLN were detected in 7 (3.1%) of the 223 patients, and complete axillary dissection was subsequently performed in all these patients but 1. Of these 7 patients, 5 had only micrometastases in the SLNs; and in the 6 patients treated with complete axillary dissection, the SLN was the only positive node.

Conclusions  Because of the low prevalence of metastases, an SLN biopsy should not be considered a standard procedure in all patients with DCIS. In patients with pure DCIS in whom the lesion is completely excised by radical surgery, an SLN biopsy could be avoided. It could be considered in patients with DCIS undergoing mastectomy, in whom there exists a higher risk of harboring an invasive component using definitive histologic features, like large solid tumors or diffuse or multicentric microcalcifications; in these patients, an SLN biopsy cannot be performed at a later operation. Complete axillary dissection may not be mandatory if the SLN is micrometastatic.